Drug information for CAVERJECT
Form
Dosage
Status
Therapeutic Equivalence
Active Ingred
Ref.
Sponsor
Document
INJECTABLE; INJECTION
0.005MG/VIAL
Prescription
ALPROSTADIL
Alprostadil
PHARMACIA AND UPJOHN
20379
2003-09-09 Letter
2002-01-15 Letter
1998-03-26 Review
INJECTABLE; INJECTION
0.01MG/VIAL
Prescription
AP
ALPROSTADIL
Alprostadil
PHARMACIA AND UPJOHN
"
INJECTABLE; INJECTION
0.02MG/VIAL
Prescription
AP (Reference Drug)
ALPROSTADIL
Alprostadil
PHARMACIA AND UPJOHN
"
INJECTABLE; INJECTION
0.04MG/VIAL
Prescription
AP (Reference Drug)
ALPROSTADIL
Alprostadil
PHARMACIA AND UPJOHN
"
INJECTABLE; INJECTION
0.005MG/ML
Discontinued
ALPROSTADIL
Alprostadil
PFIZER
20755
2003-09-09 Letter
2003-08-07 Review
INJECTABLE; INJECTION
0.01MG/ML
Discontinued
ALPROSTADIL
Alprostadil
PFIZER
"
INJECTABLE; INJECTION
0.02MG/ML
Discontinued
ALPROSTADIL
Alprostadil
PFIZER
"
Drug Adverse Effects information for CAVERJECT
Role code
Indications
Reaction
# Reports
PS
BLOOD CHOLESTEROL INCREASED
DIABETIC NEUROPATHY
1
PS
DIABETES MELLITUS
DIABETIC NEUROPATHY
5
PS
ERECTILE DYSFUNCTION
DIABETIC NEUROPATHY
1
PS
ERECTILE DYSFUNCTION
DRUG INEFFECTIVE
1
PS
GASTROOESOPHAGEAL REFLUX DISEASE
DIABETIC NEUROPATHY
1
PS
HYPERTENSION
DRUG INEFFECTIVE
3
PS
HYPERTENSION
ERECTION INCREASED
1
PS
HYPERTENSION
PAIN
1
PS
HYPERTENSION
WRONG TECHNIQUE IN DRUG USAGE PROCESS
1
PS
LIBIDO DISORDER
ANTIANDROGEN THERAPY
1
PS
LIBIDO DISORDER
DRUG INEFFECTIVE
1
PS
LIBIDO DISORDER
PROSTATIC SPECIFIC ANTIGEN INCREASED
1
PS
PROSTATIC DISORDER
DIABETIC NEUROPATHY
1
PS
RADICAL PROSTATECTOMY
ANTIANDROGEN THERAPY
1
PS
RADICAL PROSTATECTOMY
DRUG INEFFECTIVE
1
PS
RADICAL PROSTATECTOMY
PROSTATIC SPECIFIC ANTIGEN INCREASED
1
PS
UROGENITAL DISORDER
PEYRONIE'S DISEASE
1
Ads by Google